Comic highlights Cochrane and World Health Organization collaboration for positive birth experience guideline
Swiss illustrator explains his motivation for creating the comic and what he hopes it shows.The World Health Organization (WHO) has issued new recommendations to establish global care standards for healthy pregnant women and reduce unnecessary medical interventions. The new WHO guideline includes evidence from 17 Cochrane Reviews and has 56 evidence-based recommendations on what care is needed throughout labour and immediately after for the woman and her baby.Swiss illustrator, Martin Vuill ème fromThe Science of Cookies (an online French-English comic about the health and social sciences, research, and news) create...
Source: Cochrane News and Events - August 8, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

The advances of aging research to be presented at the Basel Life Congress
(InSilico Medicine, Inc.) Morten Scheibye-Knudsen, Ph.D., M.D., from University of Copenhagen will present at 5th Annual Aging and Drug Discovery Forum at Basel Life Congress, during the Basel Life Congress, Sept. 12-13, 2018, Basel, Switzerland. His talk of 'Phenotypical Landscape of Aging' will cover the latest advances in the aging and longevity science at the Aging and Drug Discovery Forum. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 8, 2018 Category: International Medicine & Public Health Source Type: news

Creamed Swiss chard
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - August 7, 2018 Category: Consumer Health News Source Type: news

Economies of integrated risk management? An empirical analysis of the Swiss Public Insurance approach to natural hazard prevention - Schwarze R, Croonenbroeck C.
In this paper we discuss the impact of prevention programmes Swiss property insurers undertake to reduce damage claims. While the cantonal public law insurer KGV tends to spend notable amounts of money on prevention programmes to avoid or decrease damage d... (Source: SafetyLit)
Source: SafetyLit - August 6, 2018 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news

Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Roche has won a monumental approval from FDA that stands to enhance its cervical cancer detection offerings. The Basel, Switzerland-based company has received a nod for its cobas Human Papillomavirus (HPV) Test as a first-line screening test for cervical cancer in women 25 and older using cervical specimens collected in SurePath preservative fluid. "Before today, laboratories did not have an FDA-approved HPV test available that could cover all of the HPV screening options supported in professional guidelines and be used with both of the primary Pap test collection media," Ann Costello, Head of Roche Tissue Diagno...
Source: MDDI - August 3, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

Insilico to present at the 2nd Annual Artificial Intelligence and Blockchain in Healthcare Forum
(InSilico Medicine, Inc.) Insilico Medicine presents at 2nd Annual Artificial Intelligence And Blockchain In Healthcare, during the Basel Life Congress, Sept. 13-14, 2018, Basel, Switzerland. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

Novartis marks a new era for migraine patients with the EU approval of Aimovig ®, a first-of-its-kind treatment specifically designed for migraine prevention
Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. Aimovig is the first and only treatment specifically designed for migraine prevention to be approved in the European Union, Switzerland, the US and Australia. (Source: World Pharma News)
Source: World Pharma News - July 30, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Origin of the species: where did Darwin's finches come from?
Gal ápagos finches have been the subject of a plethora of evolutionary studies, but where did the first ones come from?When the first of the Gal ápagos Islands arose from the ocean floor around 3m years ago, they were naked, angry, lava-spewing cones devoid of life. Now, millions of years later, they are alive with some of the world’s most iconic animals. Giant tortoises. Sea iguanas. Flightless cormorants. And those finches equipped with Swiss army knife beaks.The Gal ápagos finches are probably one of the most well-known examples of evolution and will forever be tightly linked to Charles Darwin...
Source: Guardian Unlimited Science - July 30, 2018 Category: Science Authors: Hanneke Meijer Tags: Birds Fossils Biology Evolution Science Wildlife Source Type: news

Lipari Foods Issues Voluntary Recall of Premo Brand & Fresh Grab Turkey & Swiss Submarine Sandwiches Due to Potential Contamination of Listeria Monocytogenes
Lipari Foods, LLC has issued a voluntary recall of Premo Brand and Fresh Grab turkey and Swiss submarine sandwiches produced and packaged by sister company JLM due to potential contamination of Listeria monocytogenes. Listeria monocytogenes is an organism, which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. (So...
Source: Food and Drug Administration - July 28, 2018 Category: Food Science Source Type: news

FDA: Whey Powder Behind Recent Salmonella-Linked Recalls
FRIDAY, July 27, 2018 -- Ritz and Goldfish crackers, Swiss Rolls -- they've all been tied to possible Salmonella contamination through a common ingredient, dry whey powder, according to the U.S. Food and Drug Administration. " There are no confirmed... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2018 Category: Pharmaceuticals Source Type: news

Adherence to guidelines when evaluating fitness-to-drive in the elderly: a practice review of Swiss physicians - Sebo P, Haller DM, Favrat B, Huber P, Mueller Y, Vaucher P.
OBJECTIVE: We aimed to explore the extent to which general practitioners (GPs) in Western Switzerland adhere to Swiss recommendations when assessing fitness-to-drive in the elderly. METHODS: A random sample of 500 GPs practicing in Vaud, Neuchatel ... (Source: SafetyLit)
Source: SafetyLit - July 27, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Whey Powder Blamed for Salmonella Tied to Ritz Crackers, Goldfish: FDA
THURSDAY, July 26, 2018 -- Ritz and Goldfish crackers, Swiss Rolls -- they've all been tied to possible salmonella contamination through a common ingredient, dry whey powder, U.S. officials say. " There are no confirmed illnesses related to these... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 26, 2018 Category: General Medicine Source Type: news

Roche lifts veil on patent that earned it billions but soon expires
Roche on Thursday lifted its veil of secrecy over a patent that has reaped billions of dollars over the years but is due to expire on Dec. 18, depriving the Swiss drugmaker of a key source of income. (Source: Reuters: Health)
Source: Reuters: Health - July 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche reports very strong performance in the first half of 2018
Group sales increase 7% at constant exchange rates and in Swiss francs (Source: Roche Media News)
Source: Roche Media News - July 26, 2018 Category: Pharmaceuticals Source Type: news

German Elanix Biotechnologies raises $9m
Regenerative medicine developer Elanix Biotechnologies said today it has raised $9.1 million (EU €7.8 million) with the opportunity to raise an additional $2.6 million (EU €2.1 million) through a private placement. The Germany-based company said that funds in the round are slated to support expanding its product portfolio, distribution and sales network and an e-commerce campaign for the company’s advanced care products. Elanix said that it raised funds through an offering to current shareholders, with each shareholder offered a single new share for $3.23 (EU €2.75) for every ten shares they already ow...
Source: Mass Device - July 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Regenerative Medicine Elanix Source Type: news

Even More Snacks Are Being Recalled Over the Salmonella Fears Affecting Goldfish and Ritz Crackers
Swiss Rolls and bread are the latest products disappearing from store shelves amidst a string of food recalls also affecting Goldfish and Ritz crackers. Due to possible salmonella contamination, Flowers Foods, Inc. is recalling Swiss Rolls sold under a variety of brand names nationwide, as well as Captain John Derst’s Old Fashioned Bread sold in Alabama, Florida, Georgia, North Carolina and South Carolina, the Food and Drug Administration (FDA) announced. It appears that Flower Foods uses the same potentially tainted whey powder, sourced from Associated Milk Producers Inc., that prompted Pepperidge Farm and Mondelez...
Source: TIME: Health - July 25, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Recalls Source Type: news

Salmonella Spurs Recall of Swiss Rolls, Bread
TUESDAY, July 24, 2018 -- Possible Salmonella contamination has led to the recall of rolls and bread made by Flowers Foods, according to the U.S. Food and Drug Administration. The recall includes Swiss Rolls distributed across the United States and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Flowers Foods Issues Voluntary Recall on Mrs. Freshley ’s and Other Brands of Swiss Rolls and Captain John Derst’s Old Fashioned Bread
As a precautionary measure, Flowers Foods, Inc. (NYSE: FLO) is voluntarily recalling Swiss Rolls sold under the brand names Mrs. Freshley ’s, Food Lion, H-E-B, Baker’s Treat, Market Square, and Great Value, distributed nationwide, and Captain John Derst’s Old Fashioned Bread distributed in Alabama, Florida, Georgia, North Carolina, and South Carolina, due to the potential presence of Salmonella in an ingredient, whey powder. The ingredient recall was initiated by a third-party whey powder manufacturer and supplier. No illnesses have been reported in connection with the recalled items. See below for list o...
Source: Food and Drug Administration - July 23, 2018 Category: Food Science Source Type: news

Roche wins CE Mark for Accu-Chek Solo insulin micropump
Roche (OTC:RHHBY) said today that it won CE Mark clearance for its Accu-Chek Solo insulin micropump system. The company plans to launch a pilot commercialization phase for its device in the coming weeks in Austria, Poland, Switzerland and the U.K. Get the full story at our sister site, Drug Delivery Business News. The post Roche wins CE Mark for Accu-Chek Solo insulin micropump appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat Roche Source Type: news

Health Highlights: July 23, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Salmonella Spurs Recall of Swiss Rolls Possible salmonella contamination has led to the recall of rolls and bread made by Flowers Foods, Inc. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 23, 2018 Category: General Medicine Source Type: news

FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
London UK; Philadelphia US; Geneva, Switzerland - July 20, 2018 -- GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 20, 2018 Category: Drugs & Pharmacology Source Type: news

Swiss Rolls recalled over potential salmonella contamination
Flowers Foods calls back Swiss Rolls sold under numerous brand names, as well Captain John Derst's Old Fashioned Bread, due to possible salmonella contaminaition (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 20, 2018 Category: Consumer Health News Source Type: news

Swiss, German drugmakers join U.S. price freeze
Roche, Bayer and Germany's Merck KGaA became the latest drug companies to freeze prices in the United States, amid increased scrutiny by the Trump administration of medicine costs. (Source: Reuters: Health)
Source: Reuters: Health - July 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Radiation from smartphones could trigger memory loss in teenagers, new study reveals
Researchers from the Swiss Tropical and Public Health Institute studied nearly 700 adolescents between the ages of  12 and 17 in Switzerland (stock image). (Source: the Mail online | Health)
Source: the Mail online | Health - July 20, 2018 Category: Consumer Health News Source Type: news

Roche gets breakthrough status for Alzheimer's test Elecsys
The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - July 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Swiss regulators to overhaul export certification system
By Stewart Eisenhart, Emergo Group Swissmedic, Switzerland’s medical device market regulator, will replace its current processes for issuing export certificates as well as manufacturing certificates with an online system in order to prevent delays and free up resources. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees. The post Swiss regulators to overhaul export certification system appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Emergo Group Source Type: news

Roche takes Tecentriq hit on survival data
Roche's hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback on Thursday, when a trial failed to deliver survival data the Swiss drugmaker needs to challenge rival Merck. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Reminder: Invitation to Roche's Half Year Results 2018, Thursday 26th July 2018 - Live video webcast and conference call
Roche will publish its Half Year Results for 2018 prior to the opening of the Swiss Stock Exchange on Thursday, 26th July 2018. (Source: Roche Investor Update)
Source: Roche Investor Update - July 19, 2018 Category: Pharmaceuticals Source Type: news

Roche still awaiting Tecentriq survival data in key study
Roche's Tecentric immunotherapy mixed with chemotherapy has not yet achieved a hoped-for overall survival target in first-line lung cancer treatment, the Swiss drugmaker said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis to pay 95 million euros to Galapagos, MorphoSys for skin drug
Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology. (Source: Reuters: Health)
Source: Reuters: Health - July 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Mobile phone radiation may affect memory performance in adolescents
(Swiss Tropical and Public Health Institute) Radiofrequency electromagnetic fields may have adverse effects on the development of memory performance of specific brain regions exposed during mobile phone use. These are the findings of a study involving nearly 700 adolescents in Switzerland. The investigation, led by the Swiss Tropical and Public Health Institute (Swiss TPH), will be published on Thursday, July 19, 2018 in the peer-reviewed journal Environmental Health Perspectives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 19, 2018 Category: International Medicine & Public Health Source Type: news

Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Novartis posts Q2 beat, promises to hold off on drug price hikes
Shares in Novartis (NYSE:NVS) were up today after the company beat expectations on Wall Street with its second-quarter financial results. The Switzerland-based company posted profits of $7.77 billion, or $3.34 per share, on sales of $13.16 billion for the three months ended June 30. Novartis saw its quarterly sales climb 7% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Novartis posts Q2 beat, promises to hold off on drug price hikes appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 18, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Novartis Source Type: news

Novartis shelves US price increases
Swiss pharma group’s move comes after Trump criticised rising costs in sector (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 18, 2018 Category: Pharmaceuticals Source Type: news

Polares Medical raises $25m
Preclinical Swiss medtech group Polares Medical said today it closed a $25 million funding round to support its mitral valve repair technologies. Funding in the round was led by Decheng Capital and joined by Endeavour Vision, IDO Investments, Earlybird Venture Capital and Wellington Partners, the company said. Polares Medical is developing a “hemi-replacement” solution for the mitral valve through which the posterior leaflet is replaced with a prosthetic leaflet designed to enhance coaptation with the native anterior leaflet. “Hemi-replacement represents a new treatment paradigm for mitral regurgitation, ...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Funding Roundup polaresmedical Source Type: news

Reva lands new partner in Italy for bioresorbable scaffold
Reva Medical (ASX:RVA) said today that it inked a deal with Bio Vascular Group to distribute Reva’s Fantom bioresorbable scaffold in Italy. The partnership expands Reva’s commercial activities to Italy, adding to its ongoing efforts in Germany, Switzerland, Austria and Turkey. Get the full story at our sister site, Drug Delivery Business News. The post Reva lands new partner in Italy for bioresorbable scaffold appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Vascular Wall Street Beat Reva Medical Inc. Source Type: news

Roche touts new flu drug as Tamiflu suffers generics hit
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche lauds new flu drug trial as Tamiflu suffers generics hit
Swiss drugmaker Roche's hopes of regaining ground in the influenza market have been boosted after a late-stage study showed its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche nabs trial win for investigational anti-viral flu drug
Roche said on Tuesday its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications from flu, a boost to the Swiss drugmaker's efforts to win approval for the single-dose, oral anti-viral medicine. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Democrats allege Trump lawyer had broad contacts with Novartis
Swiss pharmaceutical company sought ‘access to key policymakers’ after 2016 election (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 13, 2018 Category: Pharmaceuticals Source Type: news

Verbal and non-verbal aggression in a Swiss university emergency room: a descriptive study - Kaeser D, Guerra R, Keidar O, Lanz U, Moses M, Kobel C, Exadaktylos AK, Ricklin ME.
Workplace violence (WPV) by patients and visitors is a hazard in many emergency departments (ED), with serious consequences for both staff and patients. Patients with a migratory background seem to be prone to being involved in WPV. We therefore reviewed a... (Source: SafetyLit)
Source: SafetyLit - July 12, 2018 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

Gerresheimer to acquire Sensile Medical and its drug-delivery tech
Gerresheimer plans to acquire Swiss medical technology company Sensile Medical and its array of liquid drug delivery devices. The buyout is a perfect fit in Gerresheimer’s portfolio, the company explained, since it will boost Gerresheimer’s drug delivery offerings and add new digital and electronic capabilities into the mix. Get the full story at our sister site, Drug Delivery Business News. The post Gerresheimer to acquire Sensile Medical and its drug-delivery tech appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Mergers & Acquisitions Pharmaceuticals gerresheimer Sensile Medical AG Source Type: news

FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
London UK; Philadelphia US; Geneva, Switzerland - 12 July 2018 - GSK and Medicines for Malaria Venture (MMV) today announced that the Antimicrobial Drugs Advisory Committee (AMDAC) of the United States Food and Drug Administration (FDA) voted that... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Once with lofty plans, Novartis now closing East Bay unit, cutting 140 jobs
Novartis AG will shutter its infectious diseases unit, closing an operation it moved from the Boston area to Emeryville seven years ago and cutting about 140 jobs. The Switzerland-based company (NYSE: NVS) told employees Wednesday that it will shut down antibacterial and antiviral research — a move that affects a number of related work, such as pharmacology, protein sciences and informatics — while retaining the 150 employees who make up a tropical dise ases unit the company moved a year ago… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 12, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Once with lofty plans, Novartis now closing East Bay unit, cutting 140 jobs
Novartis AG will shutter its infectious diseases unit, closing an operation it moved from the Boston area to Emeryville seven years ago and cutting about 140 jobs. The Switzerland-based company (NYSE: NVS) told employees Wednesday that it will shut down antibacterial and antiviral research — a move that affects a number of related work, such as pharmacology, protein sciences and informatics — while retaining the 150 employees who make up a tropical dise ases unit the company moved a year ago… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 11, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Hospital disaster preparedness in Switzerland over a decade: a national survey - Dell'Era S, Hugli O, Dami F.
OBJECTIVE: The present study aimed to provide a comprehensive assessment of Swiss hospital disaster preparedness in 2016 compared with the 2006 data. METHODS: A questionnaire was addressed in 2016 to all heads responsible for Swiss emergency depart... (Source: SafetyLit)
Source: SafetyLit - July 10, 2018 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news

Medication practices and experiences of older adults discharged home from hospital: a feasibility study protocol - Roux P, Pereira F, Santiago-Delefosse M, Verloo H.
BACKGROUND: Switzerland's aging population raises pressing questions about maintaining older adults in their home environments and the problems associated with managing complex treatments requiring medication in such contexts. Few studies have examined old... (Source: SafetyLit)
Source: SafetyLit - July 6, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Molecule combos show promise against autoinflammatory diseases
Two small molecule combinations have shown potential for treating autoinflammatory diseases in a recent study in Switzerland. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 5, 2018 Category: Consumer Health News Source Type: news

Culturally shared metaphors expand contemporary concepts of resilience and post-traumatic growth: contrasting an indigenous Brazilian community and a Swiss rural community - Meili I, Heim E, Maercker A.
The metaphorical concepts resilience and post-traumatic growth (PTG) reflect the contemporary Western understanding of overcoming highly challenging life events. However, it is known that across different cultures, a broad range of metaphoric... (Source: SafetyLit)
Source: SafetyLit - July 5, 2018 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news

Switzerland weighs relaxing marijuana ban
ZURICH (Reuters) - Switzerland, which permits low potency cannabis but bans most marijuana for recreational use, aims to allow pilot studies on ways to relax its laws, its government said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - July 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news